Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Judith A. Reinsdorf currently holds 1,276.33 shares of Nurix Therapeutics, Inc. (NRIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Judith A. Reinsdorf has been a net seller of NRIX stock. They have purchased $0 and sold $11.7M worth of shares.
Judith A. Reinsdorf's most recent insider trade was on Sep 30, 2026, when they sold 91.43 shares at $306.26 per share.
Judith A. Reinsdorf serves as Executive at Nurix Therapeutics, Inc. (NRIX). They have executed 124 insider transactions totaling $11.7M over their tenure at the company.
Judith A. Reinsdorf holds the position of Executive at Nurix Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Judith A. Reinsdorf has shown a selling trading pattern, with $0 in total purchases and $11.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Judith A. Reinsdorf was on Feb 8, 2019, when they sold $942.6K worth of DNB shares. This transaction involved 6,500.69 shares at $145.00 per share.
Judith A. Reinsdorf currently owns 1,276.33 shares of Nurix Therapeutics, Inc. (NRIX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Judith A. Reinsdorf's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Judith A. Reinsdorf has 124 Form 4 filings on record as an insider at Nurix Therapeutics, Inc..
Set alerts for Judith A. Reinsdorf and 40,000+ other insiders.